Home › Guides › Ingredient notes
Regenerative Skincare: Where Peptides Fit
The regenerative narrative pulls together peptides, growth factors and exosomes. What each is, where the rules differ, and what to ask.
“Regenerative skincare” has become an umbrella term covering three quite different things: peptides, growth factors and exosomes. They are sold under the same narrative and they carry very different regulatory positions. For a buyer, the distinction is the whole conversation.
Three categories, not one
| Category | What it is | Regulatory position |
|---|---|---|
| Cosmetic peptides | Defined short-chain peptides with an INCI entry | Established cosmetic ingredients in most markets |
| Growth factors | Proteins, larger and less stable than peptides | Restricted or uncertain in several markets; usually not a cosmetic ingredient |
| Exosomes | Vesicles of biological origin, not a defined chemical | Contested; not a standard cosmetic ingredient, and rules differ by market |
The practical consequence: a formulation that includes a peptide is a normal cosmetic product. A formulation that includes an exosome is a product whose regulatory status someone has to establish before it can be sold.
Why the narrative lumps them together
Because the consumer story is identical — “skin that repairs itself” — while the chemistry, the documentation and the risk are not. Marketing copy written for one category gets applied to the others, and the buyer inherits the mismatch.
What to ask before specifying a peptide for a regenerative-positioned product
- Is there an INCI entry? If not, it is not a cosmetic ingredient, whatever the supplier calls it.
- What is the declared function? Cosmetic claims must describe what the ingredient does in the product, not a biological outcome in the user.
- What does the COA cover? A defined peptide has a purity figure and a mass. A complex biological material does not, and that absence is itself information.
- What does the supplier say about market access? A supplier who will not discuss the regulatory position of a novel material is telling you something.
Where peptides have the advantage
Three practical reasons peptides carry the regenerative narrative better than the alternatives: they are defined molecules with an INCI name; their documentation is standard, so a COA means something; and their handling is understood, so a formulator can build a stable product around them without inventing a process.
Positioning without overclaiming
The strongest cosmetic positioning for a peptide is about the formulation, not the biology: a specified ingredient at a stated level, in a base that keeps it stable, with documentation that a buyer can check. That story survives regulatory scrutiny and does not need to be rewritten when the next ingredient trend arrives.
Frequently asked questions
Are peptides the same as growth factors?
No. Peptides are short chains with defined structures and INCI entries; growth factors are larger proteins with a different regulatory position.
Are exosomes cosmetic ingredients?
Their status is contested and rules differ between markets. Before selling a product containing them, the regulatory position has to be established rather than assumed.
Why do peptide products get grouped with regenerative claims?
Because the consumer narrative is shared, even though the chemistry, documentation and risk are not.
What makes a peptide a safer choice for a launch?
A defined structure, an INCI name, a standard COA with purity and mass, and a handling profile formulators already understand.
Can I describe a peptide product as regenerative?
Describe what the ingredient does in the formulation rather than a biological outcome in the user. Claims about how the product works are defensible; claims about the body are not.